Blood Purification
Red blood cell exchange
Red blood cell exchange (erythrocytapheresis) removes the patient's red blood cells with an apheresis machine and replaces them with matched donor red cells in the same session, without raising the blood volume. It is used when the red cells themselves are the problem: an abnormal hemoglobin, or a parasite living inside them.

What is red blood cell exchange?
Red blood cell exchange (erythrocytapheresis) is an apheresis procedure that removes your own red blood cells and replaces them with compatible donor erythrocytes in the same session. Unlike a simple transfusion it does not raise the total blood volume or the thickness of the blood, which matters for patients in whom volume overload or hyperviscosity is a danger.
It is the one apheresis method on our ward that targets cells rather than plasma. The other methods, plasma exchange, H.E.L.P. apheresis and immunoadsorption, treat what is dissolved in the plasma. Red cell exchange is for the cases where the red cells themselves carry the problem: an abnormal hemoglobin as in sickle cell disease, or a parasite that lives inside the cell, as in babesiosis and malaria.
How does it work?
Blood is drawn through a venous line into an apheresis machine that spins it in a centrifuge and separates the red cells from plasma, white cells and platelets. Your red cells are diverted into a waste bag while typed and crossmatched donor red cells are infused at the same rate. Plasma, platelets and white cells are returned to you through the second line.
The machine calculates the volume to be exchanged from your weight, hematocrit and the target set by the physician: in one session 60 to 90 percent of the red cell mass can be replaced. The whole process is automated and continuously monitored so that the blood volume and the circulation stay stable from the first minute to the last.
Before the first session the blood bank types your blood and crossmatches every donor unit against it. That step takes longer than the exchange itself and is the reason a session is planned a day ahead.
What conditions is it used for?
Used for sickle cell disease, severe babesiosis, severe malaria in exceptional cases, polycythemia vera and selected hemolytic anemia. Not for unstable circulation or a bloodstream infection on the day; a physician decides from the blood film and laboratory values.
Show all indications and exclusions
- Sickle cell disease, in acute complications and as a scheduled program to keep the sickle hemoglobin low
- Severe babesiosis with a high share of infected red cells or failing organs
- Severe malaria with a very high parasite load, as an exception rather than a rule
- Polycythemia vera, when the red cell mass must be lowered quickly
- Severe autoimmune hemolytic anemia, in selected cases
Who it is not for: patients whose circulation is unstable, who have a severe infection of the bloodstream on the day, or whose veins will not carry the flow. Patients with many previous transfusions are screened for antibodies against red cell antigens first, because matching takes longer in that case. A physician decides from the blood film, the laboratory values and your history.
Could this belong in your plan?
That depends on your findings, not on the therapy. Write to the International Office with a short history; it requests your records afterwards, and a physician reviews them before the video consultation and tells you whether this treatment belongs in your program.
What a session feels like
The day before
The blood bank types your blood and crossmatches the donor units.
Before
A nurse places a line in each arm, checks blood pressure and pulse, and confirms the volume of cells to exchange, which sets the session length.
During
The exchange runs automatically under continuous monitoring, and each donor unit is checked against your wristband. Tingling or a feeling of cold is treated on the spot.
Afterwards
A short rest while the nurse checks your temperature and the puncture sites. A blood count the next morning shows what the exchange achieved.
Evidence and safety
The evidence is strong in sickle cell disease. In babesiosis it is limited: the 2021 IDSA guideline suggests red cell exchange for severe disease with high parasitemia, on low-certainty evidence.
Show studies, risks and side effects
The evidence is strong in sickle cell disease, where the American Society of Hematology recommends exchange over simple transfusion in named situations in its 2020 transfusion guideline (Chou et al., 2020), and the American Society for Apheresis grades the indications by category in its 2023 guideline (Connelly-Smith et al., 2023). In babesiosis the evidence is limited: the 2021 IDSA guideline suggests red cell exchange for severe disease with high parasitemia, on low-certainty evidence (Krause et al., 2021), and the question is under study in a multicenter US cohort published in 2026 (STOP-BABESIOSIS Investigators, 2026). In severe malaria a review of the evidence base found no demonstrated survival benefit, and the US CDC no longer recommends exchange transfusion as a routine adjunct (Tan et al., 2013).
What this means for a Lyme patient with a babesia co-infection: the standard is antimicrobial treatment, and red cell exchange is reserved for the rare severe case. Where it is used outside the guideline indications it is an individual treatment attempt, decided with the patient after medical consultation.
Safety: the procedure carries the risks of any transfusion, including allergic and febrile reactions and, rarely, reactions to a mismatched antigen, which the typing and crossmatching are designed to prevent. The apheresis itself can lower blood pressure for a short time; the World Apheresis Association registry describes the pattern of adverse events across apheresis procedures, most of them mild (Vrielink et al., 2023).
How it fits the program
Red cell exchange is not a routine part of any program at St. George Hospital; it is held for the severe case. In the Lyme program the laboratory work-up at admission includes the blood film and the babesia tests described on the co-infections page; when a babesia infection is found, the antimicrobial part of the Lyme treatment plan is adjusted, and exchange is discussed only if the parasite load or the organ values call for it. For patients who need plasma treated rather than cells, the ward uses H.E.L.P. apheresis, immunoadsorption or plasma exchange; the apheresis overview compares the five methods in one table.
Costs depend on the number of donor units and sessions. After a physician has reviewed your findings you receive a written, itemized cost overview; what it covers and how the invoice is written is explained under costs and insurance.
Common questions about red blood cell exchange
Is red blood cell exchange the same as a blood transfusion?
No. A transfusion adds donor red cells on top of your own and raises the blood volume and thickness. An exchange removes your red cells while the donor cells go in, so the volume stays the same and the share of abnormal or infected cells falls in one session. Your plasma, platelets and white cells are returned to you.
Does red blood cell exchange hurt?
Beyond the two venous lines there is little to feel. The exchange runs automatically for 1.5 to 3 hours while a nurse watches your blood pressure and pulse. Tingling from the citrate or a feeling of cold can occur and is treated on the spot. Most patients rest or read.
Is red blood cell exchange safe?
It carries the risks of any transfusion: allergic reactions, a fever reaction, and in rare cases a reaction to a mismatched antigen, which is why every unit is typed and crossmatched against your blood first. The apheresis itself can lower blood pressure for a short time. Patients are monitored throughout and for a period afterwards.
When is it used in babesiosis?
Only in severe babesiosis, when the share of infected red cells is high or organs are failing, as the 2021 IDSA guideline describes. For the milder babesia co-infection we see in Lyme patients, antimicrobial treatment is the standard, and exchange is not part of the plan. A physician decides case by case from the blood film and the laboratory values.
How much does red blood cell exchange cost?
The cost depends on the number of donor units and on whether more than one session is needed. After a physician has reviewed your findings you receive a written, itemized cost overview; the costs page explains what it covers and how the invoice is written.
Used in these departments
References
- American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020. PMID 31985807
- Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. Clin Infect Dis 2021. PMID 33501959
- Red Blood Cell Exchange Transfusion for Severe Babesiosis. JAMA Intern Med 2026. PMID 41910966
- Exchange transfusion for severe malaria: evidence base and literature review. Clin Infect Dis 2013. PMID 23800940
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice: The Ninth Special Issue. J Clin Apher 2023. PMID 37017433
- The world apheresis association registry, 2023 update. Transfus Apher Sci 2023. PMID 37827962
Send a free inquiry
The initial inquiry is free of charge. The International Office reviews your message and your case directly and gets back to you.
- Phone
- +49 8061 398-0
- Hours
- Mon–Thu 08:00–17:00, Fri 08:00–14:00 German time (CET/CEST); in the US Mon–Thu 2–11 a.m. ET, Fri 2–8 a.m. ET.
Munich Airport (MUC), about 60 minutes by car.